SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-068690
Filing Date
2020-06-02
Accepted
2020-06-02 08:36:09
Documents
2
Effectiveness Date
2020-06-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2021561d1_defa14a.htm DEFA14A 38828
2 GRAPHIC image_001.jpg GRAPHIC 4493
  Complete submission text file 0001104659-20-068690.txt   46270
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35366 | Film No.: 20935649
SIC: 2834 Pharmaceutical Preparations